Audience

GLP-1 Past Users panel (US)

GLP-1 Past Users (US): a public Ask Brox audience of Brox clones, each built from a long-form interview with a real person. Every insight fielded on this panel, newest first.

3 insights·0 studies

What did the GLP-1 Past Users panel say?

  1. #

    67.5%

    67.5% of past GLP-1 users rely most on eating less or eating differently on their own to keep the weight off, and 17.5% on exercise or a fitness routine. — After stopping a GLP-1, 67.5% keep the weight off by changing their diet on their own and 17.5% by fitness; a $29 maintenance program would draw 62.0%, a $149 one 19.3%

    base 166

  2. #

    35.3%

    35.3% of US past GLP-1 users say side effects were the main reason they stopped, and 31.2% the monthly cost or losing insurance coverage — Why past GLP-1 users stop, and what brings them back: side effects (35.3%) and cost (31.2%) lead, and the fix must match the reason, with 94.3% of cost quitters wanting coverage under $50 and 60.0% of side-effect quitters a lower dose

    base 170

  3. #

    59.1%

    59.1% of past GLP-1 users would likely restart within six months at $99 a month out of pocket, against 13.8% at $349 and 72.7% with a $25 insurance copay — Past GLP-1 users would restart at $99 a month (59.1%), but those who quit over side effects hold out even at a $25 copay

    base 159

What has Brox published on glp-1 past users panel (us)?Newest first

What do people ask about glp-1 past users panel (us)?

After stopping a GLP-1, what do past users turn to for keeping the weight off: a diet program, fitness, supplements or nothing?
In November 2026, 67.5% of US past GLP-1 users said they rely most on eating less or eating differently on their own to keep the weight off after stopping (n=166), against 17.5% on exercise, 12.0% on nothing in particular and 2.4% on a structured diet program.Read the insight
Why did past GLP-1 users stop, and what would bring them back?
In October 2026, US past GLP-1 users most often said they stopped because of side effects (35.3%) or cost and lost coverage (31.2%, n=170), and the change that would bring them back matched the reason: 94.3% of cost quitters chose coverage under $50 a month and 60.0% of side-effect quitters a lower dose.Read the insight
Why do people stop taking a GLP-1, and what would make a past user restart?
Among US past GLP-1 users, 59.1% say they would likely restart within six months at $99 a month out of pocket, against 13.8% at $349 and 72.7% with a $25 insurance copay (n=159, September 2026).Read the insight

Other audiences

How should you read these findings?

Where the numbers come from. Every figure on this site is a predicted response from Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The base under each figure is the number of clones behind it.

Where the real data comes from. The long-form video interviews with the real people the clones are built from. A quote is always shown with the interview line it was predicted from.

What you can take away. Insights publish their tabulation as CSV and JSON: question, option, count, percentage and base. Never per-person rows.

Ask this of your own customers: humans@brox.ai